Alliance for Microbicide Development, founded in 1998, is a nonprofit, multidisciplinary, advocacy organization focused on speeding the development of microbicides to prevent HIV and other sexually transmitted infections.
The Bill & Melinda Gates Foundation is a non-profit organization created in 2000 to help people lead healthy, productive lives. In developing countries, the foundation focuses on improving health and ending hunger and extreme poverty.
CDC, part of the U.S. Department of Health and Human Services, focuses on protecting and improving the public health through health promotion, prevention of disease, injury and disability, and preparing for new health threats.
CHAVI, which was established by NIAID as part of the Global HIV/AIDS Vaccine Enterprise, is designed to answer basic science questions relevant to HIV vaccines and to conduct early phase HIV vaccine clinical trials at clinical sites around the world.
CONRAD is focused on facilitating the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections.
GHAVE is a consortium of organizations committed to the development of a preventive HIV vaccine by implementing shared scientific plans, mobilizing resources, and improving international collaborations.
IAVI was founded in 1996 to speed discovery of an HIV vaccine, partners with private companies, academic institutions, and government agencies, including the National Institutes of Health (NIH).
IPM is a non-profit product development partnership established in 2002 to accelerate the development and availability of a safe and effective microbicide to prevent HIV infection among women in developing countries.
Office of the U.S. Global AIDS Coordinator, part of the U.S. Department of State, leads the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Launched in 2003 by President George W. Bush, PEPFAR aims to combat global HIV/AIDS.
Pox Protein Public-Private Partnership (P5) was established in 2010 to build on the results of the RV144 result and to advance and ultimately license HIV pox-protein vaccine candidates that have the potential to achieve a broad public health impact. The collaborative team includes NIAID, the Bill & Melinda Gates Foundation, the NIAID-funded HIV Vaccine Trials Network, the U.S. Military HIV Research Program, Sanofi Pasteur, and Novartis Vaccines.
USAID supports long-term and equitable economic growth internationally by promoting agriculture and trade; global health; democratic principles, conflict prevention and humanitarian assistance.
UNAIDS, orchestrates the efforts and resources of 10 United Nations system organizations to help prevent new HIV infections, care for people living with HIV, and mitigate the impact of the epidemic. As part of the United Nations, UNAIDS works with the World Health Organization to determine how results obtained from NIAID research studies should be applied around the world.
USMHRP was established in 1985 to protect U.S. troops entering endemic HIV areas and is dedicated to HIV vaccine development, prevention, disease surveillance, and HIV care and treatment. NIAID plans and executes HIV/AIDS research projects with USMHRP through an interagency agreement.
WHO is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends. Based on results from NIH studies, WHO and UNAIDS guide health ministries and aid organizations in determining how research findings should be applied to the provision of health services in different parts of the world.
back to top
Last Updated May 12, 2009